Trending Now
Azitra (AZTR) Makes Strides with New Patents and Public Offering
Azitra, Inc. (NYSE American: AZTR) had a whirlwind day on the stock market, closing at $4.97, up an impressive 206.79%. However, the...
Kodiak Sciences Inc (KOD): A Promising Bet in the Biopharmaceutical Space...
In the bustling arena of biopharmaceutical advancements, Kodiak Sciences Inc. (NASDAQ:KOD) is emerging as a key player, particularly in the field of...
Metagenomi, Inc. (MGX): A Game Changer in Gene Editing and Therapeutic...
In a remarkable demonstration of market optimism, Metagenomi, Inc. (MGX) has seen its share price soar by an astonishing 124.89% to...
Popular News
INOVIO (NASDAQ: INO) Receives Approval to Continue Third Part of Phase...
INOVIO (NASDAQ: INO) has received approval from India's Central Drugs Standard Control Organisation's Drug Controller General of India to continue its phase 3 part...
MAKE IT MODERN
LATEST REVIEWS
atai Life Sciences N.V. (NASDAQ: ATAI) Announce Q3 2021 Results And...
atai Life Sciences N.V. (NASDAQ: ATAI) has announced its Q3 2021 financial results for the quarter ending September 30, 2021, and offered a corporate...
MAKE IT MODERN
PERFORMANCE TRAINING
Inovio Pharmaceutical Inc. (NASDAQ:INO) Receives $71 Million Funding And Expands Executive Leadership To Advance...
Inovio Pharmaceutical Inc. (NASDAQ:INO) shares jumped almost 15% after the company announced that it had received $71 million from the Department of Defense to...
ProQR Therapeutics N.V. (NASDAQ: PRQR) Announce Seporfarse Study in LCA10 Treatment Failed to Meet...
ProQR Therapeutics N.V. (NASDAQ: PRQR) has revealed that its viral Phase 2/3 Illuminate study of sepofarsen for CEP290-Mediated Leber congenital amaurosis 10 (LCA10) treatment...
Geron Corporation (NASDAQ:GERN) Reports Q3 2020 Financial Results And Progress Of Clinical development Programs
Geron Corporation (NASDAQ:GERN) has announced its financial results for the three months ended September 30, 2020, in which it ended with $247 million in...
Grindr Inc (NYSE:GRND) technical setup looks bullish post merger
Grindr Inc (NYSE:GRND) surged last Friday after the LGBTQ social networking platform's merger with special purpose acquisition company (SPAC) Tiga Acquisition Corp....
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM)...
Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM), a trailblazer in the development of Antibody Radiation Conjugates (ARCs) and targeted radiotherapy treatments, is at...
MAKE IT MODERN
